LeukoDx / Accellix Information

LeukoDx’s mission is to deliver cost-effective, highly sensitive and actionable diagnostic information at the point of care via a novel automated IVD flow cytometry platform. Founded in 2009, LeukoDx’s technology is based on technology initially developed for NASA at CalTech. To date, the Company has developed Accellix its compact reader for single use test-specific cartridges, and an application for the rapid confirmation of sepsis, a condition associated with high morbidity and mortality with no existing reliable diagnostic solution.